Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Combinatorial Chemistry
|
December 11, 2007
Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods
Richard A Houghten, Clemencia Pinilla, Marc A Giulianotti, et al.
The ISME Journal
|
April 12, 2026
Cultivation and Molecular Profiling Reveal Ammonia-Oxidizing Archaea as Skin Commensals
Alexander Mahnert, Maximilian Dreer, Ülkü Perier, et al.
Plos One
|
August 15, 2015
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder
Daniela Brunner, Patricia Kabitzke, Dansha He, et al.
Neuropharmacology
|
September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex
Wiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Molecules (Basel, Switzerland)
|
March 13, 2015
Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound
Irene Sola, Elisabet Viayna, Tània Gómez, et al.
Journal of Medicinal Chemistry
|
December 17, 2011
Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile
Hankun Zhang, Werner Tückmantel, J Brek Eaton, et al.
Journal of Medicinal Chemistry
|
August 30, 2012
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands
Han-Kun Zhang, J Brek Eaton, Li-Fang Yu, et al.
Neurobiology of Disease
|
May 26, 2009
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled, Bassem F El-Khodor, Monica Patry, et al.
Nature Communications
|
June 9, 2016
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
Abdellatif Benraiss, Su Wang, Stephanie Herrlinger, et al.
JCI Insight
|
October 24, 2022
Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model
Deanna M Marchionini, Jeh-Ping Liu, Alberto Ambesi-Impiombato, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Combinatorial Chemistry
|
December 11, 2007
Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods
Richard A Houghten, Clemencia Pinilla, Marc A Giulianotti, et al.
The ISME Journal
|
April 12, 2026
Cultivation and Molecular Profiling Reveal Ammonia-Oxidizing Archaea as Skin Commensals
Alexander Mahnert, Maximilian Dreer, Ülkü Perier, et al.
Plos One
|
August 15, 2015
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder
Daniela Brunner, Patricia Kabitzke, Dansha He, et al.
Neuropharmacology
|
September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex
Wiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Molecules (Basel, Switzerland)
|
March 13, 2015
Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound
Irene Sola, Elisabet Viayna, Tània Gómez, et al.
Journal of Medicinal Chemistry
|
December 17, 2011
Chemistry and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile
Hankun Zhang, Werner Tückmantel, J Brek Eaton, et al.
Journal of Medicinal Chemistry
|
August 30, 2012
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands
Han-Kun Zhang, J Brek Eaton, Li-Fang Yu, et al.
Neurobiology of Disease
|
May 26, 2009
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled, Bassem F El-Khodor, Monica Patry, et al.
Nature Communications
|
June 9, 2016
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
Abdellatif Benraiss, Su Wang, Stephanie Herrlinger, et al.
JCI Insight
|
October 24, 2022
Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model
Deanna M Marchionini, Jeh-Ping Liu, Alberto Ambesi-Impiombato, et al.
Page
of 4